The research found that mice with Alzheimer's disease symptoms improved when a certain brain protein was suppressed.

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.

During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...

Diagnosing Alzheimer’s, a neurodegenerative disease, is complicated and costly. A study in RI could help speed up the process ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...

Researchers are examining whether samples collected show accurately certain biomarkers which denote abnormal proteins in the brain. Volunteers in the ongoing study undergo cognitive tests, an MRI and ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Researchers connecting pieces of the massive Alzheimer's puzzle are closer to slotting the next one in place, with yet ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr Michael Sandberg, whose mother had Alzheimer's disease, took part in the trial [BBC] An international trial is examining ...